Skip to content
PIL Logo

Distamine 125/250mg Film-coated tablets

Last Updated on eMC 15-Jan-2014 View document  | Alliance Pharmaceuticals Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15-Jan-2014 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect

Updated on 27-Nov-2012 and displayed until 15-Jan-2014

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration

Updated on 10-Aug-2012 and displayed until 27-Nov-2012

Reasons for adding or updating:

  • Updates to formatting

Updated on 11-Apr-2011 and displayed until 10-Aug-2012

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions

Updated on 10-Dec-2008 and displayed until 11-Apr-2011

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 08-Nov-2005 and displayed until 10-Dec-2008

Reasons for adding or updating:

  • Change of trade or generic name
  • Change to appearance of the medicine
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change of inactive ingredient
  • Change to drug interactions
  • Change to storage instructions
  • Change to date of revision

Updated on 23-Sep-2004 and displayed until 08-Nov-2005

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Correction of spelling/typing errors
  • Change to date of revision
  • Change to side-effects

Updated on 14-Apr-2003 and displayed until 23-Sep-2004

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Company contact details

Alliance Pharmaceuticals

Company image
Address

Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB

Fax

+44 (0)1249 466 977

Telephone

+44 (0)1249 466 966

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

d-penicillamine

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue